Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

Clinical trial NCT05397665 · COMPLETED

Trial details

NCT number: NCT05397665
Sponsor: Applied Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hereditary Neuropathy Caused by SORD Deficiency

Start date: 2022-01-01
Primary completion: 2024-10-12
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.